Revenue Recognition - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Disaggregation of Revenue [Line Items]
Net Revenue	$ 19,668	$ 16,124
Drug products
Disaggregation of Revenue [Line Items]
Net Revenue	65	221
Concentrates Products
Disaggregation of Revenue [Line Items]
Net Revenue	19,603	15,903
U.S.
Disaggregation of Revenue [Line Items]
Net Revenue	17,931	14,445
U.S. | Drug products
Disaggregation of Revenue [Line Items]
Net Revenue	0	159
U.S. | Concentrates Products
Disaggregation of Revenue [Line Items]
Net Revenue	17,931	14,286
Rest of World
Disaggregation of Revenue [Line Items]
Net Revenue	1,737	1,679
Rest of World | Drug products
Disaggregation of Revenue [Line Items]
Net Revenue	65	62
Rest of World | Concentrates Products
Disaggregation of Revenue [Line Items]
Net Revenue	1,672	1,617
Product Sales – Point-in-time | Drug product sales
Disaggregation of Revenue [Line Items]
Net Revenue	0	159
Product Sales – Point-in-time | Concentrates product sales
Disaggregation of Revenue [Line Items]
Net Revenue	18,131	15,427
Product Sales – Point-in-time | U.S. | Drug product sales
Disaggregation of Revenue [Line Items]
Net Revenue	0	159
Product Sales – Point-in-time | U.S. | Concentrates product sales
Disaggregation of Revenue [Line Items]
Net Revenue	16,459	13,810
Product Sales – Point-in-time | Rest of World | Drug product sales
Disaggregation of Revenue [Line Items]
Net Revenue	0	0
Product Sales – Point-in-time | Rest of World | Concentrates product sales
Disaggregation of Revenue [Line Items]
Net Revenue	1,672	1,617
License Fee – Over time | Drug license fee
Disaggregation of Revenue [Line Items]
Net Revenue	65	62
License Fee – Over time | Concentrates product license fee
Disaggregation of Revenue [Line Items]
Net Revenue	1,472	476
License Fee – Over time | U.S. | Drug license fee
Disaggregation of Revenue [Line Items]
Net Revenue	0	0
License Fee – Over time | U.S. | Concentrates product license fee
Disaggregation of Revenue [Line Items]
Net Revenue	1,472	476
License Fee – Over time | Rest of World | Drug license fee
Disaggregation of Revenue [Line Items]
Net Revenue	65	62
License Fee – Over time | Rest of World | Concentrates product license fee
Disaggregation of Revenue [Line Items]
Net Revenue	$ 0	$ 0